Department of Cardiology, Sint Lucas Andreas Hospital, the Netherlands.
Neth Heart J. 2009 Oct;17(10):373-7. doi: 10.1007/BF03086287.
Objective. To determine the influence of transoesophageal echocardiography (TEE) on therapy and prognosis in patients with cryptogenic transient ischaemic attack (TIA) or ischaemic stroke under the age of 50 years.Methods and results. We evaluated all patients aged 50 and under who were referred to our university hospital for cryptogenic TIA or ischaemic stroke during the period 1 January 1996 to 31 December 2004. All patients underwent both transthoracic echocardiography (TTE) and TEE. Patients with known pre-existent heart disease, such as atrial fibrillation, were excluded. Eighty-three patients with TIA (22) and ischaemic stroke (61) were enrolled. Mean age was 39+/-8 years (range 18 to 50). In 30% of the patients TEE detected one or more potential cardioembolic source, compared with 10% for TTE (p=0.003). Standard treatment (aspirin 38 mg daily) was changed in 7% of the patients due to the TEE findings. Complete followup was obtained in 93% with an average of 5+/-3 years. Twelve recurrences occurred; two out of six patients (33%) with therapy change and ten out of 71 (14%) of the patients without therapy change had a recurrent TIA or ischaemic Stroke.Conclusion. In patients with cryptogenic TIA or ischaemic stroke, TEE is superior to TTE in the detection of a potential cardiac source of embolism. However, findings obtained by TEE only influence the already initiated treatment in a small percentage of patients. The recurrence rate both in the group with and without therapy change is high. (Neth Heart J 2009;17:373-7.).
目的。确定经食管超声心动图(TEE)对年龄在 50 岁以下的隐源性短暂性脑缺血发作(TIA)或缺血性中风患者的治疗和预后的影响。
方法和结果。我们评估了 1996 年 1 月 1 日至 2004 年 12 月 31 日期间因隐源性 TIA 或缺血性中风而转至我们大学医院的所有年龄在 50 岁及以下的患者。所有患者均接受了经胸超声心动图(TTE)和 TEE 检查。排除了已知存在心脏病(如心房颤动)的患者。共纳入 83 例 TIA(22 例)和缺血性中风(61 例)患者。平均年龄为 39+/-8 岁(18-50 岁)。与 TTE(10%)相比,TEE 发现一个或多个潜在心源性栓塞源的患者占 30%(p=0.003)。由于 TEE 结果,7%的患者改变了标准治疗(每日 38 毫克阿司匹林)。93%的患者获得了 93%的完整随访,平均随访时间为 5+/-3 年。发生了 12 次复发;治疗改变的 6 例患者中有 2 例(33%)和未改变治疗的 71 例患者中有 10 例(14%)发生了 TIA 或缺血性中风复发。
结论。在隐源性 TIA 或缺血性中风患者中,TEE 在检测潜在心源性栓塞源方面优于 TTE。然而,TEE 发现仅在一小部分患者中已启动的治疗产生影响。治疗改变组和未改变治疗组的复发率均较高。(荷兰心脏杂志 2009;17:373-7.)。